Literature DB >> 30340234

The Relationship Between Bone Mineral Density and Type 2 Diabetes in Obese Children and Adolescents at the Time of Initial Diagnosis.

Hae Sang Lee1, Jong Seo Yoon1, Kyu Jung Park1, Jung Sub Lim2, Jin Soon Hwang1.   

Abstract

Long-term effects of type 2 diabetes mellitus (T2D) on bone health remain unclear. The objective of this study was to assess the possible association of bone mineral density (BMD) at multiple sites with T2D after correcting for several potential confounders such as age, sex, Tanner stage, and BMI known to affect BMD in adolescents with newly developed T2D. In this cross-sectional study, 17 children and adolescents with T2D and 59 age, sex, and BMI-matched controls were included. All subjects underwent dual-energy X-ray absorptiometry to measure regional and whole-body composition with Lunar Prodigy at the time of initial diagnosis. A BMD Z-score was calculated using data from healthy Korean children and adolescents after adjusting for height-for-age. The mean age of all subjects was 12.9±2.4 years (range, 8.3-18.3 years). BMDht Z-scores for lumbar spine and total body after adjusted for age, sex, BMI SDS, and Tanner stage were not significantly different between patients and controls. However, BMDht Z-scores for femur neck and bone mineral apparent density (BMAD) Z-scores of lumbar spine were significantly lower in T2D patients than those in healthy controls. HOMA-IR or HbA1c was not associated with BMDht Z-scores at multiple sites. BMDht Z-scores at multiple sites except femur neck in adolescents with newly developed T2D were similar to those in obese controls after adjustment for potential confounders. © Georg Thieme Verlag KG Stuttgart · New York.

Entities:  

Mesh:

Year:  2018        PMID: 30340234     DOI: 10.1055/a-0755-2799

Source DB:  PubMed          Journal:  Horm Metab Res        ISSN: 0018-5043            Impact factor:   2.936


  3 in total

1.  Comparison of Bone Mineral Density in US Adults With Diabetes, Prediabetes and Normoglycemia From 2005 to 2018.

Authors:  Jing Yuan; Pu Jia; Jian-Bo Zhou
Journal:  Front Endocrinol (Lausanne)       Date:  2022-05-30       Impact factor: 6.055

Review 2.  Impact of Type 2 Diabetes Mellitus and Antidiabetic Medications on Bone Metabolism.

Authors:  Hae Sang Lee; Jin Soon Hwang
Journal:  Curr Diab Rep       Date:  2020-11-27       Impact factor: 4.810

Review 3.  Fracture risk assessment in diabetes mellitus.

Authors:  Weiwei Chen; Min Mao; Jin Fang; Yikai Xie; Yongjun Rui
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-02       Impact factor: 6.055

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.